准Cdc42:心血管疾病的新方法
Rupali Chauhan1, Sushma Devi1, Thakur Gurjeet Singh1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Current protein & peptide science
|July 31, 2025
概括
细胞分裂控制蛋白42同源 (Cdc42) 是心血管健康的关键调节者,影响从血管完整性到心脏发育的功能. 准Cdc42对新型心血管疾病治疗和早期检测有希望.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 心血管疾病 (CVD) 是全球主要的健康负担,需要新的诊断和治疗分子点.
- 心血管疾病的新兴目标包括细胞分裂控制蛋白42同类 (Cdc42),Rho家族GTPase对心血管生理和病理至关重要.
研究的目的:
- 本综述阐明了Cdc42在心血管并发症中的多样性作用.
- 它强调了Cdc42在内皮功能,血管光滑肌调节,心脏发育,炎症和脂质代谢中的重要性.
主要方法:
- 这是一篇综述性文章,综合了关于Cdc42在心血管系统中的功能的现有研究.
- 它分析了Cdc42参与信号通路的数据,包括影响脂质代谢和胰岛素敏感性的信号通路.
主要成果:
- Cdc42在维持内皮屏障完整性和调节血管光滑肌肉细胞表型方面发挥着至关重要的作用.
- 它参与心脏发育,免疫反应调节,并影响脂质运输和胰岛素信号传递.
- Cdc42显示出作为早期心脏病检测生物标志物和治疗点的潜力.
结论:
- Cdc42是心血管过程的多方面的调节者,为创新的心血管疾病预防和治疗策略提供了潜力.
- 由于其广泛存在,针对Cdc42的挑战需要进一步研究组织特异调制和下游效应因子.
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
259
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
259
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Coronary Artery Disease I: Introduction
58
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
58


